Tenon Medical Inc has a consensus price target of $4.5, established from looking at the 3 latest analyst ratings. The last 3 analyst ratings were released from Benchmark, Benchmark, and Benchmark on April 15, 2024, March 10, 2023, and June 21, 2022. With an average price target of $5 between Benchmark, Benchmark, and Benchmark, there's an implied 521.20% upside for Tenon Medical Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/15/2024 | Buy Now | 272.72% | Benchmark | Bruce Jackson | $5 → $3 | Maintains | Speculative Buy | Get Alert |
03/10/2023 | Buy Now | 645.43% | Benchmark | Jackson Ader | → $60 | Reiterates | → Buy | Get Alert |
06/21/2022 | Buy Now | 645.43% | Benchmark | Bruce Jackson | → $60 | Initiates | → Speculative Buy | Get Alert |
The latest price target for Tenon Medical (NASDAQ: TNON) was reported by Benchmark on April 15, 2024. The analyst firm set a price target for $3.00 expecting TNON to rise to within 12 months (a possible 272.72% upside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for Tenon Medical (NASDAQ: TNON) was provided by Benchmark, and Tenon Medical maintained their speculative buy rating.
There is no last upgrade for Tenon Medical.
There is no last downgrade for Tenon Medical.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenon Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenon Medical was filed on April 15, 2024 so you should expect the next rating to be made available sometime around April 15, 2025.
While ratings are subjective and will change, the latest Tenon Medical (TNON) rating was a maintained with a price target of $5.00 to $3.00. The current price Tenon Medical (TNON) is trading at is $0.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.